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Abstract
Background: Chlamydia, caused by the bacterium Chlamydia trachomatis(C. trachomatis), is the most common
sexually transmitted disease. The incidence is not clear due to the asymptomatic nature of early stage of infections.
The incidence of Chlamydia has not been fully investigated in the Chinese Han population. Since chronic infection
with can C. trachomatis can lead to infertility in males and females, it is important to determine the impact of
infection on clinical outcomes. The aim of this study is to explore the epidemiology of C. trachomatis in subfertile
couples and to determine whether infections will adversely affect clinical outcomes after assisted reproduction
technique (ART) treatment.
Methods: Subfertile patients (n = 30760) were screened in the research for C. trachomatis in our center from January
2010 to December 2014. C. trachomatis-specific DNA was detected by Taq-man PCR from semen or swabs from the
urethral, endocervix or vaginal. The control group consisted of 1140 subfertile patients without C. trachomatis infection.
The prevalence and characteristics of C. trachomatis were identified for subfertile couples and clinical outcomes were
collected and analyzed. A retrospective study was performed.
Results: Nine hundred and seventy patients were diagnosed with C. trachomatis infection, and the overall prevalence
was 3.15% in the most recent five years, with a yearly increasing. The incidence was a higher in the second half of the
year (3.40%) compared to the first half (2.69%). The age group with the highest-risk of infection with C. trachomatis was
between 26 to 35 years old, and in about one third of the couples, both partners were infected. The basic parameters
and clinical outcomes were not statistically significant between different the groups (P > 0.05), even though some
minor data were different (P < 0.05).
Conclusions: C. trachomatis is a common infection in subfertile people and it is essential to test for this organism
in ART couples’ screening. This study identified no adverse on clinical outcomes after successful treatment of C.
trachomatis infection, regardless of gender, age and number of C. trachomatis copies.
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Plain English summary
One of the most common bacterial sexually transmitted
disease is Chlamydia, caused by Chlamydia trachomatis
(C. trachomatis), the exact incidence of Chlamydia is
unknown because the infection is often asymptomatic in
the early stage. The incidence of Chlamydia it has not
been fully investigated in the Chinese Han population.
Since chronic infection with C. trachomatis can induce
infertility in males and females. The aim of the study is
to explore the epidemiology of C. trachomatis in sub-
fertile couples and to determine adverse effects on clin-
ical outcomes after assisted reproduction technique
(ART) treatments.
A total of 30760 subfertile patients were tested for C.
trachomatis in our center from January 2010 to December
2014. C. trachomatis-specific DNA was detected by Taq-
man PCR. The prevalence and characteristics of C. tracho-
matis were identified for subfertile couples and clinical
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outcomes were collected and analyzed. A retrospective
study was performed.
The overall prevalence of C. trachomatis was 3.15%
in a recent five year periods, with a yearly increase.
The incidence was slightly higher in the second half
of the year (3.40%) compared to the first half of the
year (2.69%). The age range with the highest-risk in-
fection of of C. trachomatis was between 26 and
35 years, and in about one third of the couples, both
partners had the infection. The main parameters and
clinical outcomes were not statistically significant
between the groups (P > 0.05), even though some
minor data were different (P < 0.05).
The results of this ananlysis confirm that of C. tra-
chomatis is common infection in subfertile people
and it is essential to test for the presence of this mi-
crobe as part of ART couples’s screening. This study
found no adverse effects on clinical outcomes after
the infection was cured.
Background
Chlamydia trachomatis (C. trachomatis), an intracellu-
lar bacterium, is the cause of the most frequently sexu-
ally transmitted disease (STD), resulting in about 100
million new cases annually worldwide [1]. Previous stud-
ies have reported that the prevalence of C. trachomatis
ranged from 1.7% to 17% among European women [2]
and from 1%-40% among asymptomatic men with a
longstanding history of couple infertility [3], depending
on the method of diagnosis, social background, area of
residence, occupation, gender, and among others.
Approximately 50% males and 80% females with Chla-
mydia show no symptoms in the early stage of infection,
consequently, many of these individuals remain undiag-
nosed and are often poorly or inadequately treated [4].
Therefore, the true prevalence of this infection is not
clear, and may remain unknown for several years or even
longer. Standard microbiologic tests were commonly
used to diagnosis C. trachomatis infections in the past,
but studies have proved that this method may fail to
reveal the pathogen, owing to high-proportion false
negative results [5]. Thus, the DNA amplification
method is increasingly universal. This method has a high
sensitivity (99%) and specificity (100%), and has been
accepted as the gold standard for the identification of C.
trachomatis infections. [6, 7].
Since C. trachomatis is often asymptomatic and treat-
ment is often delayed, the infection is often transmitted
to sexual partner(s) [8]. It can cause fallopian tube sal-
pingitis, cervicitis, and pelvic inflammatory disease
(PID), which in turn can cause infertility and ectopic
pregnancy in women with chronic infections [9].
Research has shown that microbiologic tests done
on semen revealed a high proportion (43%) of C.
trachomatis -specific DNA in semen from men with
azoospermia [10], suggesting that hronic progression
of C. trachomatis in the male genital tract may lead
to urethritis, epididymitis, and even obstructive azoo-
spermia [11]. Some subfertile couples are seeking
ART treatment due to STD infection.
Some studies report that the subfertile men with gen-
itourinary infection caused by C. trachomatis had
increased sperm DNA fragmentation [12], leading to
sperm apoptosis [13] and low to sperm quality [10]. In
animal experiments, C. trachomatis infection has been
shown to inhibit oocyte transport in the mouse oviduct
[14]. These studies suggest that C. trachomatis infec-
tion has the potential to negatively affect gamete for-
mation and development. Despite the advances in
knowledge about C. trachomatis infection, the impact
of prior infection C. trachomatis on clinical outcomes
after successful treatment is unknown. Therefore, the
present study was carried out to evaluate C. trachoma-
tis infection in subfertile couples I south China that
were diagnosed by Taq-man PCR, and to deteremine
whether the infection has any adverse effects on the
clinical outcomes after treatment is completed.
Methods
Study population
The study patients were recruited from couples of re-
productive age complaining of primary or secondary
infertility that came to our reproductive center for ART
treatment, from January 2010 to December 2014. For
the study, a total of 30760 patients were screened for
epidemiology statistical analysis. After fulfilling the
eligibility criteria, 970 patients were diagnosed with C.
trachomatis infection and 761 of these were included
for clinical outcomes analysis. Subfertile (n = 1140)
patients without C. trachomatis infection were re-
cruited as the control group at corresponding period.
This study was approved by the Research Ethics Com-
mittee of Shenzhen Zhongshan Urology Hospital, and
informed consent was obtained from all couples prior
to the study.
Sample collection and C. trachomatis detection
A total of 30760 testing samples (including endocervical
swab, semen and urethral swab) were obtained. Sam-
ples were collected into sterile containers and trans-
ported to the laboratory at room temperature within
2 hours. The DNA was extracted within 24 hours, ac-
cording to instructions provided in commercial kit
(Sansure Biotech, China). The endocervical and ureth-
ral swabs were placed in 1 ml normal saline; semen
samples (50 μl) were added to 950 μl normal saline,
and diluted (20×); the samples were sufficiently mixed
by vortex for 15 s. Aliquots (0.5 ml) were centrifuged
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at 12000 rpm for 10 min, and the supernatants dis-
carded. The pellets underwent lysis, mixed thoroughly
and waited for 10 min in room temperature, and were
stored at -20°Cuntil PCR analysis was performed. We
performed four different concentration reference stan-
dards (from 104 to 107) to generate draw the standard
curve, and then calculated the bacterial copy number
for positive infection samples using absolute quantifi-
cation real-time PCR methods. The kit for in vitro
clinical diagnosis relies on absolute quantification of
C. trachomatis burden (using FAM-labeled Taq-man
primer–probe set), as assessed by the inclusion of
known C. trachomatis standards. Furthermore, this
system includes a Vic-labeled internal standard pri-
mer–probe set to test for the presence of PCR inhibi-
tors. The PCR amplification was assessed using the
ABI PRISM 7500 Sequence Detection System (Applied
Biosystems, Foster City, CA). The assay set up internal
control, positive control and negative control. The
sample was deemed as positive if the number was
higher than 200/ml copies.
Ovarian stimulation protocol
All female patients received the luteal-phase gonadotrophin-
releasing hormone agonist protocol. Since the pituit-
ary was adequately suppressed (triptorelin acetate
injection; Tiantaishan Pharmaceuticals, China), ovar-
ian stimulation was induced with human menopausal
gonadotrophin (Menotropins for Injection; Livzon,
China) and recombinant FSH (Gonal-F; Merck Serono,
Switzerland). Human chorionic gonadotrophin (hCG;
Chorionic Gonadotrophin for Injection; Livzon, China)
was injected when two or more dominant follicles
reached 18 mm in diameter. Oocytes were collected
36 h after hCG administration by vaginal ultrasound
guided follicular aspiration.
Embryo culture, transfer and pregnancy evaluation
Fertilization was taken 16–18 h after IVF (day 1; oocytes
retrieved day defined as day 0) by the presence of pro-
nuclei. Zygotes were cultured in Quinn's Advantage
Cleavage Medium (Quinn's 1026; SAGE, USA) contain-
ing 10% (v/v) serum protein substitute (SAGE). On day
3, embryos were scored using morphological criteria as
previously described [15]. Grade 1 and 2 embryos were
defined as high-grade embryos. Two or three cleavage-
stage embryos (at least one high-grade embryo) were
selected for transfer and the remaining embryos were
stored in liquid nitrogen. The clinical pregnancy was
identified by ultrasound examination at 5 weeks after
the embryo transferr. The fertilization rates, cleavage
rates, clinical pregnancy rates, implantation rates, mis-
carriage rates, take baby home rates and other data were
collected and analyzed.
Statistical analysis
Continuous data were presented as mean ± standard
deviation (SD) and percentage. Mann-Whitney U test,
Pearson's chi-squared or Fisher's exact tests were used
to determine the difference. The statistical analyses
Fig. 1 The incidence of C. trachomatis in subfertile individuals from
2010 to 2014
Fig. 2 The prevalence and distribution of C. trachomatis infection in recent five years during different months
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were performed by SPSS 17.0 software (SPSS Inc,
Chicago, IL, USA). P < 0.05 was considered statistically
significant.
Results
Prevalence of C. trachomatis for subfertile patients
A total of 30760 samples were collected for the study
over a period of five years and 970 patients identified as
positive by PCR diagnostics, giving a prevalence rate of
3.15% (Fig. 1). The prevalence rate was 2.45% in 2010
and was 3.69% in 2014, showing an increasing trend
year by year. The incidence was similar between the
two genders (P > 0.05).
Prevalence of C. trachomatis during different times of
the year
As shown in Fig. 2, the incidence of C. trachomatis
was correlated with different seasons, in the past five
years, the incidence was 3.40% in the second half
year, it was slightly higher than the first half year
(2.69%), and the difference was statistically signifi-
cant (P < 0.05).
Trails eligible for inclusion in clinical outcomes analysis
After identification, and eligibility screening, 761 pa-
tients (including single and dual infection of subfertile
couples) were included in the study for clinical outcome
Fig. 3 Schematic of the recruitment in the study. Abbreviation: C. trachomatis, Chlamydia trachomatis; OR, oocyte retrieve; OPU, oocyte pick-up
Table 1 Parameters and clinical outcomes of patients with and without C. trachomatis infection
Variables C. trachomatis (+) C. trachomatis (-) P value OR (95% CI)
No. of couples 761 1140 /
Male age (mean[IQR]) 33.40 [29. -35] 33.79 [27-35] 0.874
Female age (mean[IQR]) 30.87 [24-32] 30.71 [25-32] 0.342
Duration of infertility[IQR] 4.00 [2–5] 3.76 [2–5] 0.223
Oocytes retrieved [IQR] 14.73[10–19] 14.68 [9–19] 0.529
MII rate 88.80 (9957/11213) 88.82 (14873/16746) 0.966 0.998 (0.925-1.077)
Fertilized rate 76.55 (8584/11213) 75.98 (12724/16746) 0.271 1.032 (0.976-1.021)
Cleaved rate 96.28 (8265/8584) 96.03 (12219/12724) 0.348 1.071 (0.928-1.235)
Transfer cycles 643 938 /
Transferred embryos[IQR] 2. 32 [2, 3] 2.25 [2–5] 0.036
Embryo implantation rate 32.84 (490/1492) 36.56 (770/2106) 0.021 0.848 (0.738-0.976)
Clinical pregnancy rate 52.88 (340/643) 54.69 (513/938) 0.477 0.930 (0.760-1.137)
Miscarriage rate 13.24 (45/340) 16.18 (83/513) 0.238 0.790 (0.534-1.169)
Multiple pregnancy rate 43.82 (149/340) 46.78 (240/513) 0.395 0.887 (0.674-1.169)
Take baby home rate 45.88 (295/643) 45.95 (431/938) 0.978 0.997 (0.815-1.220)
Note: + = previously-positive C. trachomatis; IQR interquartile range
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statistical analysis, (Fig. 3). Meanwhile, 1140 subfertile
couples without C. trachomatis infection were enrolled
for the control group.
Clinical outcomes in C. trachomatis infection
The basic parameters (Table 1), such as the age of
couples and duration of infertility, were similar be-
tween the two groups (P > 0.05). The number of
transferred embryos was 2.32 ± 0.59 in the C. tracho-
matis group and 2.25 ± 0.64 in control group, and
the difference was statistically significant (P < 0.05).
The implantation rate in C. trachomatis group was
32.84%, which was significantly lower than in control
group (P < 0.05), which had a rate of 36.56%. The
fertilization rate, cleaved rate, multiple pregnancy
rate, clinical pregnancy rate, miscarriage rate and
take-home baby rate were comparable between the
two groups (P > 0.05).
Clinical outcomes in different genders
A total of 761 C. trachomatis infection patients were
recruited in the study for clinical outcome analysis.
These patients underwent successful treatment for
the infections. They were further divided into two
subgroups: male (374 patients) and female subgroup
(387 patients) respectively. In the male subgroup,
the MII rate was significantly lower but the cleaved
rate was significantly higher, both differences were
reached statistically significance (P < 0.05), when
compared to the female subgroup. All other clinical
parameters were not significantly different between
genders (P > 0.05) (As shown in Table 2).
Distribution and clinical outcomes stratified by age
Patients were divided into four subgroups according to
age: ≤25 years; 26-30 years; 31-35 years and >35 years. As
shown in Fig. 4, the C. trachomatis constituent ratio dif-
ferent between the age groups. The age group having the
highest prevalence rate was 31-35(38.12%), followed by
26-30 (30.22%), >35 (26.10%) and ≤25 years (5.56%). The
basic parameters and clinical outcomes were comparable
(P > 0.05) in different age brackets, even though the mis-
carriage rate was higher and the take-home baby rate were
slight lower in advanced age group (P < 0.05) (Table 3).
Distribution and clinical outcomes versus C. trachomatis
copy number
The C. trachomatis copy numbers were mainly in
the range of 103 ~ 106 copies (Fig. 5), accounting for





P OR (95% CI)
No. of couples 374 387 /
Male age (mean[IQR]) 33.26 [30-36] 33.53 [29-36] 0.670
Female age (mean[IQR]) 30.77 [28-33] 30.97 [28-34] 0.916
Duration of infertility[IQR] 4.00 [2–5] 4.01 [2–5] 0.180
Oocytes retrieved [IQR] 14.50 [10–18] 15.00 [10-39] 0.420
MII rate 87.72 (4756/5423) 89.60 (5201/5805) 0.002 0.828 (0.737-0.931)
Fertilized rate 76.29 (4137/5423) 76.61 (4447/5805) 0.689 0.982 (0.900-1.072)
Cleaved rate 96.74 (4002/4137) 95.86 (4263/4447) 0.032 1.280 (1.020-1.604)
Transfer cycles 307 336 /
Transferred embryos [IQR] 2. 29 [2, 3] 2.35 [2, 3] 0.105
Embryo implantation rate 34.14 (240/703) 31.69 (250/789) 0.314 1.118 (0.900-1.387)
Clinical pregnancy rate 54.72 (168/307) 51.19 (172/336) 0.370 1.152 (0.845-1.572)
Miscarriage rate 13.10 (22/168) 13.37 (23/172) 0.940 0.976 (0.521-1.828)
Multiple pregnancy rate 42.86 (72/168) 44.778 (77/172) 0.723 0.925 (0.603-1.420)
Take baby home rate 49.51 (152/307) 44.64 (150/336) 0.236 1.216 (0.892-1.659)
Note: + = previously-positive C. trachomatis
Fig. 4 The distribution of C. trachomatis in different age groups
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approximately 80% of cases. Patients received ART
treatment only after thereapy and the successful
cure of infection. The longer the duration of infer-
tility, the more embryos were transferred (P < 0.05),
the other clinical parameters were similar among
the groups (P > 0.05) (Table 4).
Distribution and clinical outcomes of one-sided or two-
sided infections
For C. trachomatis positive couples, some were merely
one-sided (one partner infected), while other couples
had two sided infections (both partners infected).
We found that on third of C. trachomatis cases
were two-sided infections, and the remainder was
one-sided. However, as long as the treatment was
successful, all the clinical outcomes were not statis-
tically different between the two groups (P > 0.05)
(Table 5 and Fig. 6).
Discussion
Infertility is becoming an increasingly significant health
problem in both developed and developing countries,
undoubtedly, including China. The increase appears to
coincide with the growing role played by sexually trans-
mitted disease [16]. Here, we found that C. trachomatis
infection has no adverse effect on clinical outcomes after
C. trachomatis was thoroughly cured. This is one of the
largest epidemiological studies of genital C. trachomatis
in assisted reproductive technology patients thus far.
The prevalence of C. trachomatis in subfertile couples
in this study was 3.15%, and increased yearly from
2.45% in 2010 to 3.69% in 2014. It is slightly lower than
previous published reports, which showed varied preva-
lence rates of between 1% and 93.5% [17–19]. Discrep-
ancies of the findings in these studies might be due to
the fact that almost all of the sub-infertile patients in
our study have a regular sexual partner, and were
asymptomatic prior to the study. In other study, many
Table 3 Parameters and Clinical outcomes of C. trachomatis in different age groups
Variables ≤25 26-30 31-35 35-38
No. of couples 73 278 301 109
Duration of infertility [IQR] 2.89 [2–5] 3.48 [2–6] 4.21 [2–6] 5.50 [3–8]
Oocytes retrieved [IQR] 16.71 [10–20] 15.8 [10–18] 13.94 [9–19] 13.03 [9–18]
MII rate 90.9 (1110/1220) 88.0 (3855/4378) 89.8 (3769/4195) 86.1 (1223/1420)
Fertilized rate 77.0 (940/1220) 76.9 (3371/4378) 76.8 (3223/4195) 73.9 (1050/1420)
Cleaved rate 95.9 (902/940) 96.4 (3250/3371) 96.2 (3103/3223) 96.1 (1010/1050)
Transfer cycles 67 223 253 101
Transferred embryos [IQR] 2.30 [2, 3] 2.20 [2, 3] 2.36 [2, 3] 2.50 [2, 3]
Embryo implantation rate 34.4 (53/154) 34.0 (167/490) 31.2 (186/595) 33.2 (84/253)
Clinical pregnancy rate 52.2 (35/67) 52.9 (118/223) 52.1 (132/253) 55.4 (56/101)
Miscarriage rate 14.2 (5/35) 7.6 (9/118) 12.1 (16/132) 28.5 (16/56)
Multiple pregnancy rate 51.4 (18/35) 41.5 (49/118) 40.9 (54/132) 50.0 (28/56)
Take baby home rate 44.7 (30/67) 48.8 (109/223) 45.8 (116/253) 39.6 (40/101)
Fig. 5 C. trachomatis DNA copies/ml in subfertile couples prior to treatment
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subjects had symptoms, such as warts, ulcers, ectopy,
lesions, erythema and discharge; some had more than
one sexual partner. Other different between our study
and others include the criteria and sample size of pa-
tients, area of residence, occupation, gender, diagnostic
methods, specimen type and clinical study design.
The positive rate of C. trachomatis was 2.92% in males
and 3.04% in females, respectively, which is slightly higher
than previous reports [20]. The incidence in different
genders is close [21], in contrast to other indications of
higher rates in females than in males [22]. In these litera-
tures, the subjects are mainly women involved in prostitu-
tion; females carry an increased risk for infection based on
their anatomy as well. In contrast, the majority of patients
in this study have a regular lifetime partner, thus the risk
of sexually transmitted infections is relatively lower.
In the C. trachomatis positive group, the number of
transferred embryos was significantly higher, while the
Table 4 Parameters and clinical outcomes for different C. trachomatis copy numbers
Variables 102 103 104 105 106 107 108
No. of couples 30 177 145 178 139 80 12
Male age 34.50 ± 5.32 33.70 ± 4.73 33.59 ± 4.29 32.87 ± 4.28 33.59 ± 5.02 33.01 ± 4.12 31.83 ± 4.65
Female age 31.57 ± 3.95 30.92 ± 4.17 31.44 ± 3.87 30.22 ± 4.11 30.95 ± 3.89 30.88 ± 3.58 30.42 ± 4.74
Duration of infertility 3.07 ± 2.34 4.39 ± 3.05 4.04 ± 2.76 3.74 ± 2.72 4.12 ± 3.20 4.04 ± 2.54 2.50 ± 1.17











































Transfer cycles 20 156 125 145 123 63 11
Transferred embryos 2.10 ± 0.45 2.64 ± 0.51 2.30 ± 0.63 2.22 ± 0.60 2.20 ± 0.58 2.29 ± 0.61 2.36 ± 0.51
Embryo implantation rate 33.3 (14/42) 32.0 (128/400) 31.5 (91/288) 32.6 (105/322) 33.7 (91/270) 31.9 (46/144) 57.6 (15/26)
Clinical pregnancy rate 45.0 (9/20) 55.1 (86/156) 54.4 (68/125) 51.0 (74/145) 52.0 (64/123) 47.6 (30/63) 81.8 (9/11)
Miscarriage rate 11.1 (1/9) 10.4 (9/86) 14.7 (10/68) 10.8 (8/74) 15.6 (10/64) 15.2 (7/46) 0.0 (0/9)
Multiple rates 55.5 (5/9) 48.8 (42/86) 33.8 (23/68) 41.8 (31/74) 42.1 (27/64) 34.7 (16/46) 55.5 (5/9)
Take baby home rate 40.0 (8/20) 49.3 (77/156) 46.4 (58/125) 45.5 (66/145) 43.9 (54/123) 36.5 (23/63) 81.8 (9/11)





P value OR (95% CI)
No. of couples 271 490 /
Male age 33.28[28-36] 33.46[30-36] 0.841
Female age 30.87[27-34] 30.88[28-34] 0.996
duration 4.04[2–5] 3.98[2–5] 0.828
Oocyte retrieve 13.69[9–17] 15.31[11–19] 0.000
MII rate 88.79 (3294/3710) 88.83 (6663/7501) 0.948 0.996 (0.879-1.128)
Fertilized rate 75.61 (2805/3710) 77.04 (5779/7501) 0.091 0.924 (0.842-1.013)
Cleaved rate 96.74 (2716/2805) 96.026 (5549/5779) 0.064 1.265 (0.986-1.622)
Transfer cycles 235 408 /
Transferred embryos 2. 33[2, 3] 2.32[2, 3] 0.694
Embryo implantation rate 31.08 (170/547) 33.86 (320/945) 0.270 0.881 (0.703-1.104)
Clinical pregnancy rate 51.49 (121/235) 53.92 (220/408) 0.552 0.907 (0.658-1.251)
Miscarriage rate 14.88 (18/121) 12.27 (27/220) 0.497 1.249 (0.657-2.375)
Multiple rates 40.50 (49/121) 45.00 (99/220) 0.422 0.832 (0.530-1.304)
Take baby home rate 43.83 (103/235) 47.06 (192/408) 0.429 0.878 (0.636-1.212)
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embryo implantation rate was lower than the control
group. A possible explanation is that the female age was
higher and the duration was longer, even though these
differences were not statistically significant (P > 0.05).
Some researchers have found that the prevalence of C.
trachomatis is the highest in younger people especially
those under the age of 25 years [23]. The highest preva-
lence rate in our study was in women aged 25-35 years, in
males and females. However, the average age of patients in
our center for ART treatment is about 32 years, and most
patients were between 25 and 35 years old. Couples less
than 25 years old seldom turn to ART treatment, unless
there is a specific diagnosis reason of infertility. Advanced
age females (>38 year) were excluded in the study as well,
therefore the absolute number of patients ranging from 25
to 35 was proportionally high, resulting in a potential
sources of bias. The miscarriage rate was 14.2% in those
younger than 25 years and 28.5% in those older than
3 years. These results demonstrate that the best repro-
ductive age was between 25 to 35 years old.
In our study, about one third of the couples were had
two-sided infections and two thirds had one-sided infec-
tions; however, the clinical outcomes regarding the
success of ART therapy are comparable in these two
subgroups, suggesting that C. trachomatis infection
had no adverse effect, regardless of whether the in-
fection was present in one or both partners.
Conclusion
Chlamydia trachomatis is common infection in subfertile
people and it is critical to test for this organism before
starting the ART process. The age range of infected indi-
viduals ranged between 25 to 35 years, and about one
third of the couples had two sided infections that were
transmitted sexually. For C. trachomatis infected patients,
after a complete cure, there were no adverse effects on the
clinical outcome, regardless of their gender, age group and
number of copies.
Abbreviations
ART: assisted reproduction technique; C. trachomatis: Chlamydia trachomatis;
PID: pelvic inflammatory disease; SAGE: serum protein substitute;
STD: sexually transmitted disease
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